AI Article Synopsis

  • Atherosclerosis is a chronic inflammatory disease where inflammation significantly impacts its development, and elevated serum homocysteine (Hcy) is a key risk factor.
  • Previous research highlights the role of fatty acid binding protein 4 (FABP4) in macrophage inflammation and lipid metabolism related to Hcy, yet the details of its molecular mechanisms were unclear.
  • This study reveals that FABP4 activates the JAK2/STAT2 pathway in Hcy-induced macrophage inflammation, influenced by the actions of Rap1a and c-Src, while the suppressor of cytokine signaling 1 (SOCS1) acts as a negative feedback regulator of this pathway.

Article Abstract

Atherosclerosis is a chronic inflammatory vascular disease, and inflammation plays a critical role in its formation and progression. Elevated serum homocysteine (Hcy) is an independent risk factor for atherosclerosis. Previous studies have shown that fatty acid binding protein 4 (FABP4) plays an important role in macrophage inflammation and lipid metabolism in atherosclerosis induced by Hcy. However, the underlying molecular mechanism of FABP4 in Hcy-induced macrophage inflammation remains unknown. In this study, we found that FABP4 activated the Janus kinase 2/signal transducer and activator of transcription 2 (JAK2/STAT2) pathway in macrophage inflammation induced by Hcy. Of note, we further observed that ras-related protein Rap-1a (Rap1a) induced the Tyr416 phosphorylation and membrane translocation of non-receptor tyrosine kinase (c-Src) to activate the JAK2/STAT2 pathway. In addition, the suppressor of cytokine signaling 1 (SOCS1)-a transcriptional target of signal transducer and activator of transcription (STATs) inhibited the JAK2/STAT2 pathway and Rap1a expression via a negative feedback loop. In summary, these results demonstrated that FABP4 promotes c-Src phosphorylation and membrane translocation via Rap1a to activate the JAK2/STAT2 pathway, contributing to Hcy-accelerated macrophage inflammation in ApoE mice.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695379PMC
http://dx.doi.org/10.1038/s41374-021-00679-2DOI Listing

Publication Analysis

Top Keywords

jak2/stat2 pathway
20
macrophage inflammation
16
pathway rap1a
8
apoe mice
8
induced hcy
8
transducer activator
8
activator transcription
8
phosphorylation membrane
8
membrane translocation
8
activate jak2/stat2
8

Similar Publications

Glioblastoma is considered the most malignant central nervous system tumor. This study aimed to investigate effects of latent transforming growth factor-β binding protein-2 (LTBP2) on glioblastoma growth and associated mechanisms. LTBP2 gene transcription in glioblastoma was determined using RT-PCR.

View Article and Find Full Text PDF

The Effects of FABP4 on Cardiovascular Disease in the Aging Population.

Curr Atheroscler Rep

May 2024

Central Diagnostics Laboratory, Division Laboratory, Pharmacy, and Biomedical Genetics, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.

Purpose Of Review: Fatty acid-binding protein 4 (FABP4) plays a role in lipid metabolism and cardiovascular health. In this paper, we cover FABP4 biology, its implications in atherosclerosis from observational studies, genetic factors affecting FABP4 serum levels, and ongoing drug development to target FABP4 and offer insights into future FABP4 research.

Recent Findings: FABP4 impacts cells through JAK2/STAT2 and c-kit pathways, increasing inflammatory and adhesion-related proteins.

View Article and Find Full Text PDF
Article Synopsis
  • Atherosclerosis is a chronic inflammatory disease where inflammation significantly impacts its development, and elevated serum homocysteine (Hcy) is a key risk factor.
  • Previous research highlights the role of fatty acid binding protein 4 (FABP4) in macrophage inflammation and lipid metabolism related to Hcy, yet the details of its molecular mechanisms were unclear.
  • This study reveals that FABP4 activates the JAK2/STAT2 pathway in Hcy-induced macrophage inflammation, influenced by the actions of Rap1a and c-Src, while the suppressor of cytokine signaling 1 (SOCS1) acts as a negative feedback regulator of this pathway.
View Article and Find Full Text PDF

Background And Purpose: The protein V-domain immunoglobulin suppressor of T-cell activation (VISTA) is a novel immune-checkpoint molecule that belongs to the B7 family and regulates a broad spectrum of immune responses. So far, low MW compounds targeting VISTA for the treatment of autoimmune diseases or inflammation, have not been identified.

Experimental Approach: We developed a homology modelling for VISTA 3D structure and subsequent virtual screening for low MW ligands binding to VISTA.

View Article and Find Full Text PDF

Objective: Recent evidence suggests the substantial pathogenic role of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway in the development of low-grade chronic inflammatory response, known as "metaflammation," which contributes to obesity and type 2 diabetes. In this study, we investigated the effects of the JAK1/2 inhibitor baricitinib, recently approved for the treatment of rheumatoid arthritis, in a murine high-fat-high sugar diet model.

Methods: Male C57BL/6 mice were fed with a control normal diet (ND) or a high-fat-high sugar diet (HD) for 22 weeks.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!